Certara, Inc. Common Stock
CERTStock
$7.28−32.18%52W
Market Cap$1.10B
P/E—
Div yield—
Beta1.42
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-35.07%
Price vs S&P 500 (4W)16.10%
VGM Score51.64
Market Capitalization$1.10B
Earnings Surprise History
Q1 260.09est. 0.11
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.80
3.75
3.75
3.68
Industry Peers — Software(272)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CERTCertara, Inc. Common Stock | C | C | C | $7.28 |
| MSFTMicrosoft Corp | D | B | C | $401.10 |
| ORCLOracle Corp | D | C | D | $124.21 |
| PLTRPalantir Technologies Inc. Class A Common Stock | F | A | C | $134.44 |
| CRWDCrowdStrike Holdings, Inc. Class A Common Stock | F | A | A | $203.76 |
| SAPSAP SE | C | C | D | $161.64 |
| SHOPShopify Inc. Class A subordinate voting shares | F | B | C | $125.06 |
| CRMSalesforce, Inc. | C | B | C | $172.68 |
| NOWSERVICENOW, INC. | D | B | C | $104.01 |
| CDNSCadence Design Systems | F | C | B | $364.65 |
| NETCloudflare, Inc. Class A common stock, par value $0.001 per share | F | A | B | $272.46 |
About
Certara provides biosimulation and regulatory science software that accelerates drug development and market approval. Its modeling, simulation, and assessment solutions help pharmaceutical clients reduce clinical trial costs and timelines while enabling faster regulatory approval. The company operates globally with significant presence across the Americas, EMEA, and Asia Pacific regions.